Oruka Therapeutics 株価情報 (NASDAQ: ORKA)

最新ニュース Oruka Therapeutics (NASDAQ:ORKA) 株価情報

Oruka Therapeutics

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Oruka Therapeutics Inc

Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) has outperformed the market over the past 5 years by 5.39% on an annualized basis producing an average annual return of 22.64%. Currently, Wheaton Precious Metals has a market capitalization of $33.71 billion. 
Buying $1000 In WPM: If an investor had bought $1000 of WPM stock 5 years ago, it would be worth $3,026.12 today based on a price of $74.31 for WPM at the time of writing.
<h3>Wheaton Precious Metals's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741970714_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

Here's How Much You Would Have Made Owning Wheaton Precious Metals Stock In The Last 5 Years

WIIM

KINS

Kingstone shares are trading higher after the company reported better-than-expected Q4 adjusted EPS results and a year-over-year increase in Q4 sales results. Also, the company raised its FY25 net income per share.

PLRZ

Polyrizon shares are trading lower. The company announced that is signed a non-binding Letter of Intent with a biotech company focused on psychedelic-derived therapeutics, to develop a novel intranasal formulation for psychedelic-based treatment applications.

Shares of D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) were climbing in early trading on Friday, after the company reported <a href="https://www.benzinga.com/25/03/44329639/semtech-posts-better-than-expected-earnings-joins-rubrik-docusign-pagerduty-and-other-big-stocks-moving-higher-on-friday">upbeat fourth-quarter results</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
Roth Capital Markets On D-Wave Quantum
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/599ecad3ca17380001263601/suji-desilva">Analyst Suji Desilva</a> maintained a Buy rating, while raising the price target from $7 to $10.
D-Wave Quantum reported revenues of $2.3 million, up 23.5% sequentially but down 21% year-on-year, Desilva said. The figure came in higher than consensus, "reflecting steady QCaaS service revenue results," he added.
Bookings stood at $18.3 million, "reflected inclusions of the company's first quantum annealing computer sale booked in the quarter," the analyst stated. "We are encouraged by the growing backlog and opportunity to diversify into hardware sales beyond core QCaaS quantum cloud services," he further wrote.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Benchmark On D-Wave Quantum
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/60216a57879cba00010f246b/david-williams">Analyst David Williams</a> reiterated a Buy rating and price target of $8.
D-Wave Quantum delivered "another quarter of strong results, demonstrating continued progress across its technology, financials, customer base, and business development initiatives," Williams said. We think the peer-reviewed publication of the company's quantum supremacy demonstration is a significant achievement and was the highlight since the company's last earnings release.
The company enjoyed momentum in hardware sales, with the first on-site Advantage system sale, the analyst stated. The launch of the next-generation Advantage 2 system, anticipated for later this year, is expected to "serve as a catalyst for additional sales opportunities," he wrote.
Needham On D-Wave Quantum
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e21cde3430dee0001c717dd/quinn-bolton">Analyst Quinn Bolton</a> reiterated a Buy rating and price target of $8.50.
D-Wave Quantum "achieved quantum supremacy on a real world magnetic materials simulation problem, meaningfully strengthened its balance sheet," Bolton said. The company announced the sale of an Advantage system to the Julich Supercomputing Center in Germany, which is the first system sale in its history, he added.
While the system was booked in the fourth quarter, most of the revenue will be recognized in the first quarter of 2025, the analyst stated. "The company is engaged with three other institutions globally for quantum systems but does not expect additional system sales this year," he wrote.
QBTS Price Action: Shares of D-Wave Quantum had risen by 37.7% to $9.52 at the time of publication on Friday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43949618/cisco-and-nvidia-expand-ai-partnership-secure-us-government-authorization-for-cloud-security">Nvidia Stock Reached All-Time Highs After Jensen Huang&#8217;s CES Keynote — Will Next Week&#8217;s GTC Spark Another Surge?</a></li>
</ul>
Photo: Shutterstock

Tech

QBTS

D-Wave Quantum Analysts Highlight Strong Results, First System Sale, Growing Backlog

ADBE

ADSK

ASAN

BILL

CRWD

CVLT

CYBR

FICO

FTNT

GWRE

INTU

MANH

NTNX

OKTA

PANW

PEGA

SAIL

SHOP

SNPS

TEAM

TWLO

Shares of companies in the broader software sector are trading higher. The sector may be rising as the overall marker rebounds after falling recently on tariff concerns.

AMAT

ASML

ENTG

KLAC

LRCX

MKSI

MPWR

NVDA

NXPI

QCOM

SMTC

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SWKS

Shares of semiconductor and chip stocks are trading higher. The sector may be gaining amid an overall market rebound after experiencing recent weakness due to tariff uncertainty.

Macro Economic Events

Politics

Global

Economics

General

Russia's Putin On Talks With U.S., Says Situation Is Starting To Move; Let's See What Comes Of It; Putin On Trump's Request To Spare Lives Of Ukrainian Troops, Says 'In Case They Surrender We Guarantee We Will Save Their Lives, Ukrainian Authorities Need To Give Order To Surrender'

Gold hit a fresh record high on Thursday, with spot gold <a href="https://www.benzinga.com/25/03/44325928/gold-smashes-through-3000-mark-as-markets-brace-for-turbulence-and-fed-signals">crossing $3,000 per ounce</a>, up 1.8%. It has surged 13% in 2025, outperforming all major asset classes. On Friday, spot gold pared some of the gains and was trading at $2,982.73 as of 11:50 a.m. EST.
Needless to say, <a href="https://www.benzinga.com/etfs">gold ETFs</a>, which offer investors exposure to gold without owning the metal, have gained from this rally. Some top-performing gold ETFs include:
SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>): Tracks spot gold prices closely and has an expense ratio of 0.4%. It has risen 12% year-to-date, illustrating the strong demand for gold as a safe-haven asset.
iShares Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IAU#NYSE">IAU</a>): Follows the performance of the price of gold bullion. It carries an expense ratio of 0.25%. The ETF has climbed 12% YTD, closely mirroring gold's price action.
VanEck Vectors Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>): Focuses on gold mining stocks and carries an expense ratio of 0.5%. The ETF has gained 23.5% YTD, benefiting from rising gold prices and improved miner profitability.
VanEck Junior Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDXJ#NYSE">GDXJ</a>): Targets smaller, high-growth mining firms. The ETF has surged 22.8% YTD as speculative interest in smaller miners has picked up.
Also Read: <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44331708/billionaire-hedge-funder-adds-mining-stocks-before-gold-makes-record-highs-gold-will-go-up-paulson-says">Billionaire Hedge Funder Adds Mining Stocks Before Gold Makes Record-Highs: &#8216;Gold Will Go Up,&#8217; Paulson Says</a>
<h1 class="wp-block-heading">Surging Gold ETF Inflows</h1>
Investor interest in gold ETFs is on the rise. The World Gold Council <a href="https://www.gold.org/goldhub/research/gold-etfs-holdings-and-flows/2025/03">reported </a>recently that global physically-backed gold ETFs saw $9.4 billion in inflows in February, the highest since March 2022. This marks three consecutive months of strong inflows, pushing total assets under management (AUM) to $306 billion. Holdings have also risen to 3,353 tonnes, the highest since July 2023. 
North American flows rebounded after two months of outflows, while Asian demand remained strong and European inflows narrowed. 
<h1 class="wp-block-heading">Why Is Gold Soaring?</h1>
Simply, economic uncertainty and geopolitical risks are driving gold's rally.
President Donald Trump's administration has reignited trade war fears by threatening tariffs. The <a href="https://www.benzinga.com/government/regulations/25/03/44308014/gold-hits-record-highs-as-trade-war-fears-fuel-safe-haven-demand-mining-stocks-soar">Atlanta Federal Reserve's GDPNow model projects</a> a 2.4% contraction for the U.S. economy in the first quarter of 2025, and JPMorgan raised the probability of a recession to 40%.
A key unknown factor is also influencing gold prices. 
"A large and unknown player is driving gold's recent rally," said Ross Norman, CEO of Metals Daily Ltd., speculating that this could explain the unusual movements in gold prices.
Macquarie Group analysts are bullish, forecasting gold at $3,500 per ounce by the third quarter. "We view gold's price strength to date, and our expectation for it to continue, as primarily being driven by investors' and official institutions' greater willingness to pay for its lack of credit or counterparty risk," Macquarie wrote.
With trade tensions, recession fears and global uncertainty, demand for gold, and naturally, gold ETFs, is expected to stay strong. As price targets rise, investors seeking a hedge against volatility may find gold ETFs a compelling option.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44332599/exclusive-what-industry-experts-are-saying-about-the-openai-oracle-nvidias-100b-stargate-project-etfs-that-stand-">Exclusive: What Industry Experts Are Saying About OpenAI-Oracle-Nvidia&#8217;s $100-Billion Stargate Project &amp; ETFs That Stand To Gain</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

Commodities

ETFs

Market Vectors ETF Trust Market Vectors Gold Miners

GDXJ

Gold ETFs Shine As Spot Price Tops $3,000 During Safe-Haven Demand

Guidance (see "Disclaimer and Forward-Looking Statements" below)
For 2025, the Company's full year expectations are calculated based on anticipated net premiums earned of approximately $184 million, and are as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td rowspan="1">Guidance Metrics</td>
<td>&nbsp;</td>
<td>2025 - Current</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>2025 - Previous</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Core Business2 direct premiums written growth</td>
<td>&nbsp;</td>
<td>15% to 25%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>15% to 25%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Combined ratio</td>
<td>&nbsp;</td>
<td>81% to 85%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>82% to 86%</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net income per share - basic</td>
<td>&nbsp;</td>
<td>$1.90 to $2.30</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>$1.60 to $2.00</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Net income per share - diluted</td>
<td>&nbsp;</td>
<td>$1.75 to $2.15</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>$1.45 to $1.85</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Return on equity</td>
<td>&nbsp;</td>
<td>27% to 35%</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>24% to 32%</td>
<td>&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
The following reflects the impact of dilution to total shares outstanding for the year ended December 31, 2024 and full year 2025 guidance:
<figure class="table"> 
<table>
<tbody>
<tr>
<td rowspan="1">Common Stock Metrics</td>
<td>&nbsp;</td>
<td colspan="2">Year Ended</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">2025E</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>(shares in millions)</td>
<td>&nbsp;</td>
<td colspan="2">December 31, 2024</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Weighted average shares outstanding - basic</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">11.5</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">13.3</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Weighted average shares outstanding - diluted</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">12.4</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">14.2</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total shares outstanding as of end of period - basic</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">12.9</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">13.6</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total shares outstanding as of end of period - diluted</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">14.1</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td colspan="1">14.7</td>
<td>&nbsp;</td>
</tr>
<tr>
<td colspan="9">All changes to total shares outstanding - basic and diluted assumed for 2025 are primarily from the vesting of restricted shares and stock issued under our "at the market" offering.</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Guidance

Kingstone Companies Revises FY25 Net Income From $1.45-$1.85 To $1.75-$2.15 Per Share; Net Premiums Earned Of ~$184M

Emeren Group shares are trading lower after the company reported worse-than-expected Q4 financial results.

Oppenheimer analyst Michael Carrier maintains Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) with a Outperform and raises the price target from $30 to $39.

Price Target

Analyst Ratings

PHAR

Oppenheimer Maintains Outperform on Pharming, Raises Price Target to $39

J.P. Morgan analyst Bill Peterson shared key takeaways from the conference hosted for Plug Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>), <a target="_blank" href="https://www.benzinga.com/quote/PLUG/analyst-ratings" rel="noreferrer noopener">with a Neutral rating.</a>
The analyst writes that the discussions mainly centered on the demand outlook across its three key verticals, cost-saving initiatives, and the financial roadmap for the year.
Although not a central topic, there are signs of potential support from the new administration for Plug&#8217;s Texas DOE loan. Meanwhile, the timeline for the first loan disbursement, if approved, remains unclear, adds the analyst.
The analyst notes that Plug recently lowered its full-year revenue guidance to ~$700 million-$800 million from the previous $850 million-$950 million, citing macro headwinds and policy uncertainty.
Peterson expects Electrolyzers to be the top revenue driver in 2025, with growth weighted toward the second half due to commissioning timelines—potentially mirroring 2024&#8217;s ~60% growth, though he remain conservative.
Earlier this month, Plug Power disclosed that it expects Project Quantum Leap to reduce annual expenses in the range of <a target="_blank" href="https://www.benzinga.com/25/03/44103584/plug-stock-drops-as-hydrogen-leader-struggles-with-margins-initiates-cost-reduction-plan" rel="noreferrer noopener">$150 million to $200 million</a>.
The analyst says that if the company&#8217;s plan works as expected, the fourth quarter could potentially be a strong breakeven quarter, driven by increased revenue and cost savings, though he still expects this to be much further in the future.
Yesterday, the company got a contract from Southwire, a North American manufacturer of wire and cable, to implement a clean hydrogen ecosystem at their new&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44303579/plug-power-to-power-southwires-texas-facility-with-hydrogen-forklifts-cutting-1m-pounds-of-co2-annually" rel="noreferrer noopener">distribution site in Dallas-Fort Worth, Texas</a>.
Investors can gain exposure to the stock via&nbsp;Global X Hydrogen ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYDR#NASDAQ">HYDR</a>) and&nbsp;ETF Series Solutions Defiance Next Gen H2 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HDRO#NYSE">HDRO</a>).
Price Action: PLUG shares are up 1.52% at $1.675 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44324509/palantirs-warp-speed-gains-momentum-six-new-customers-onboard" target="_blank" rel="noreferrer noopener">Palantir&#8217;s Warp Speed Gains Momentum: Six New Customers Onboard</a></li>
</ul>

Analyst Color

Equities

Large Cap

Reiteration

ETF Series Solutions Defiance Next Gen H2 ETF

HDRO

HYDR

PLUG

Plug Power's 2025 Bet On Electrolyzers—J.P. Morgan Sees Growth But Stays Conservative

Earnings

Reported Thursday March 13, 2025: Kingstone Companies Q4 Adj EPS $0.46 Beats $0.42 Estimate, Sales $35.97M Up From $28.68M YoY

The Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) meme coin, associated with President Donald Trump, has plummeted 84% from its all-time high of $73.4, with its market cap shrinking from $14.5 billion to $2.3 billion, though it gained 13% in the last 24 hours <a href="https://www.benzinga.com/money/trump-coin-price-prediction">to trade at $12.</a>
What Happened: Launched on the Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) blockchain in January, just before Trump's presidential inauguration, the token initially soared alongside the MELANIA (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MELANIA</a>) meme coin, with their combined market value briefly surpassing that of Occidental Petroleum, a major oil producer valued at over $50 billion at the time.
Despite the recent daily uptick, the TRUMP coin's sharp decline reflects broader challenges for Trump-branded cryptocurrencies amid a volatile meme coin market.
The TRUMP coin's website notes, "Trump Memes are intended for collecting and entertainment purposes only. They are not financial instruments or investments." 
Its vesting schedule includes a 30-day lock period for the team, followed by phased token releases, a structure also used by the MELANIA coin. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44326594/trump-administration-signals-aggressive-cost-neutral-bitcoin-accumulation-strategy">Trump Administration Signals Aggressive Cost-Neutral Bitcoin Accumulation Strategy</a>
The launch capitalized on Trump's growing crypto advocacy, following his November 2024 election win and an executive order earlier in March, establishing a strategic Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reserve with seized assets, which initially spurred interest in related projects.
The Solana blockchain, known for its high-speed transactions and low fees, provided a scalable platform for the token's launch, but even this technical advantage has not shielded it from significant losses.
The decline follows a period of heightened attention on Trump family ventures in the crypto space. 
World Liberty Financial (WLFI), a DeFi project backed by Trump and his sons Eric, Donald Jr., and Barron, raised $590 million through token sales by March 2025, including a $550 million public sale, as reported by ICO Drops. 
The WLFI project, launched in September 2024, saw a boost from the TRUMP and MELANIA meme coins, which drove interest in its tokens despite initial lukewarm demand. 
Additionally, Tron (CRYPTO: TRON) founder Justin Sun invested $30 million in WLFI in November 2024, becoming an advisor, while Web3Port added $10 million in January 2025, reflecting institutional interest in <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44327489/trump-backed-world-liberty-financial-raises-590m-in-token-sales">Trump-related crypto initiatives. </a>
Despite this, the TRUMP meme coin's 95% value drop underscores the volatility of such assets, even amid a recovering meme coin market.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44321245/ripple-sec-lawsuit-nears-end-will-xrp-be-classified-as-commodity-like-ethereum">Ripple-SEC Lawsuit Nears End: Will XRP Be Classified As Commodity Like Ethereum?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$MELANIA

$SOL

$TRUMP

Donald Trump's Official Meme Coin, Worth $14.5 Billion On Inauguration Day, Is Down To $2.3 Billion

BITF

CLSK

COIN

HIVE

MARA

MSTR

RIOT

Shares of Bitcoin miners and crypto-linked stocks are trading higher amid a rebound in Bitcoin.

Morgan Stanley analyst Ronald Kamdem maintains Vornado Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNO#NYSE">VNO</a>) with a Equal-Weight and raises the price target from $26 to $28.

Morgan Stanley Maintains Equal-Weight on Vornado Realty, Raises Price Target to $28

HAIN

Hain Celestial shares are trading lower after JP Morgan lowered its price target on the stock from $6 to $5.

Morgan Stanley analyst Connor Lynagh maintains HF Sinclair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) with a Overweight and lowers the price target from $51 to $50.

DINO

Morgan Stanley Maintains Overweight on HF Sinclair, Lowers Price Target to $50

Morgan Stanley analyst Connor Lynagh maintains Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) with a Underweight and lowers the price target from $19 to $18.

Morgan Stanley Maintains Underweight on Delek US Hldgs, Lowers Price Target to $18

BZAI

Blaize Holdings shares are trading higher after the company announced a partnership with Turbo Federal for federal use cases.

Press Releases

Oruka Therapeutics Announces $200 Million Private Placement

Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress

Health Care

Oruka Therapeutics to Present at Multiple November Investor Conferences

Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference

Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)

Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-001, its Novel Half-life Extended Anti-IL-23p19 Antibody

Oruka Therapeutics to Present at Multiple March Investor Conferences

Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting

Comments

Oruka Therapeutics

ニュース

最新ニュース Oruka Therapeutics (NASDAQ:ORKA) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル